Senthil Lingaratnam

6PUBLICATIONS
36CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular targetsPharmacogenomicsPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 16, 2026
Implementing Pharmacogenomics in Contemporary Hospital Care: Insights from Multidisciplinary Knowledge Exchange.

|Aug 28, 2025
Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Michelle K Yong, Karin Thursky, Megan Crane

|Mar 19, 2025
Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers.

Marliese Alexander, Chiao Xin Lim, Senthil Lingaratnam

|Nov 29, 2024
Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trial.

Sarah Glewis, Senthil Lingaratnam, Benjamin Lee

|Aug 23, 2024
Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year review.

Senthil Lingaratnam, Safeera Yasmeen Hussainy, Alexandra Murphy

|May 03, 2024
A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer.

Senthil Lingaratnam, Mahek Shah, Joseph Nicolazzo

Pageof 1

Frequent Collaborators

2 joint publications

Sarah Glewis

2 joint publications

Craig Underhill

2 joint publications

Marliese Alexander

1 joint publications

Joseph Nicolazzo